Total Arterial Revascularization (TAR)

  • End date
    Mar 22, 2024
  • participants needed
  • sponsor
    Meshalkin Research Institute of Pathology of Circulation
Updated on 22 January 2021
angina pectoris
stable angina
bypass graft
arterial disease


Total arterial revascularisation with in-situ confihuration of BITA is superior than y-graft in patients underwent CABG.


The main hypothesis of the trial is that in-situ configuration of bilateral internal thoracic arteries is superior than Y-graft configuration for MACCE (mortality, myocardial infarction, repeat revascularization, stroke) during mid-term follow-up in patients with CAD who is shedueled for CABG.

Condition Coronary Artery Disease, Coronary artery bypass graft, Coronary heart disease, Cardiac Ischemia, Myocardial Ischemia, cabg, coronary artery bypass, coronary bypass, coronary artery bypass surgery
Treatment Y-Graft, In-Situ
Clinical Study IdentifierNCT03753048
SponsorMeshalkin Research Institute of Pathology of Circulation
Last Modified on22 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age between 25 yrs and 70 yrs?
Gender: Male or Female
Do you have any of these conditions: Coronary heart disease or Coronary artery bypass graft or Coronary Artery Disease?
Do you have any of these conditions: coronary artery bypass or cabg or coronary bypass or Cardiac Ischemia or coronary artery bypass surgery or Coronary Artery Disease or Myocardial Ische...?
Coronary Artery Disease
Stable angina
The need for revascularization of anterior descending and obtuse margin arteries accoring to the 2018 ESC/EACTS Guidelines on myocardial revascularization
Informed Consent Form

Exclusion Criteria

The diameter of the target arteries is less than 1 mm
Stenosis of the subclavian arteries more than 60%
Previous cardiac surgery
STEMI less than 3 month
BMI >35
COPD with FEV1 <60%
Cancer with life expectancy less than 5 years
Concomitant pathology that requires simultaneous surgical treatment
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note